The prevention of acute renal failure through the intervention in the DNA repair system.
The prevention of acute renal failure through the intervention in the DNA repair system.
批准号:
15590846
负责人:
HISHIDA Akira
金额:
$2.24万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
在这项研究中,我们评估了参与细胞周期调节和DNA修复的蛋白质在顺铂(CDDP)诱导的急性肾功能衰竭(ARF)中的表达和作用。外髓细胞周期调控蛋白(p21、p27、细胞周期蛋白B1和细胞周期蛋白D1)和DNA修复相关蛋白(增殖细胞核抗原、Gadd45和Gadd153)的表达显著增加,在CDDP后3d达到高峰。顺铂后5d,亚砷酸钠(SA)可减轻肾小管损伤,增加Scr。SA可增强GDDP诱导的p27表达增加,但抑制细胞周期蛋白B1和细胞周期蛋白D1的表达。SA诱导的肾毒性减弱与肾小管损伤细胞中增殖细胞核抗原和GADD153的表达增加有关。给予p21反义寡核苷酸(ODN)后,皮质近端小管(PT)细胞摄取的p21阳性细胞数量减少,皮质PT损伤加重,但对外髓外条的影响不明显。结果表明:(1)顺铂肾毒性诱导了与细胞周期调控和DNA修复相关的蛋白表达;(2)SA诱导的顺铂肾毒性减弱与p27表达增加、细胞周期蛋白B1和细胞周期蛋白D1表达降低有关,均导致细胞周期停滞于G1/S和G2/M期;(3)DNA修复相关蛋白表达增强也与顺铂肾毒性减弱有关。
英文摘要
In this study, we evaluated the expressions and the roles of proteins involved in cell cycle regulation and DNA repair in cisplatin(CDDP)-induced acute renal failure(ARF). CDDP-induced tubular damage and the increase in serum creatinine (Scr) were observed at day 3 and peaked at day 5. The expressions of cell cycle regulatory proteins(p21, p27, cyclin B1 and cyclin D1) and DNA repair-related proteins(PCNA, GADD 45 and GADD 153) were significantly increased in the outer medulla, reaching peak levels at 3 days after CDDP. Sodium arsenite (SA) attenuated tubular damage and increased Scr at 5 day after CDDP. SA augmented GDDP-induced increment of p27 but suppressed the increased expression of cyclin B1 and cyclin D1. SA-induced attenuation of nephrotoxicity was associated with enhanced expression of PCNA and GADD 153 in damaged tubular cells.The administration of p21 antisense oligodeoxynucleotide(ODN), which was mainly uptaken by cortical proximal tubule(PT) cells, induced a decrease inn the number of p21-positive PT cells in the cortex and aggravated cortical PT damage, but did not affect these in the outer stripe of outer medulla. The antisense also did not alter Scr level at day 5.Our findings indicated that (1) proteins related to cell cycle regulation and DNA repair are induced in CDDP nephrotoxicity, (2) the SA-induced attenuation of CDDP nephrotoxicity is associated with increased expression of p27 and decreased expression of cyclin B1 and cyclin D1, they all induce cell cycle arrest at G1/S and G2/M, and (3) enhanced expression of DNA repair-related proteins is also associated with attenuation of CDDP-nephrotoxicity.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1007/s10157-003-0263-x
发表时间:
2004-03
期刊:
Journal of Clinical and Experimental Nephrology
影响因子:
--
作者:
[H. Yasuda;Akihiko Kato;T. Miyaji;Hua Zhou;A. Togawa;A. Hishida]
通讯作者:
H. Yasuda;Akihiko Kato;T. Miyaji;Hua Zhou;A. Togawa;A. Hishida
DOI:
10.1016/j.taap.2004.04.003
发表时间:
2004-10-15
期刊:
TOXICOLOGY AND APPLIED PHARMACOLOGY
影响因子:
3.8
作者:
[Zhou, H, Kato, A, Hishida, A]
通讯作者:
Hishida, A
Plasma protein extravasation and vascular endothelial growth factor expression with endothelial nitric oxide synthase induction in gentamicin-induced acute renal failure in rats.
庆大霉素诱导的大鼠急性肾衰竭中内皮一氧化氮合酶诱导的血浆蛋白外渗和血管内皮生长因子表达。
DOI:
--
发表时间:
2004
期刊:
Virchows Arch 444(4)
影响因子:
--
作者:
[Tetsuo Goto, Yoshihide Fujigaki, Di Fei Sun, Tatsuo Yamamoto, Akira Hishida]
通讯作者:
Akira Hishida
Fujigaki Y, Sun DF, Goto T, Hishida A: "Temporary changes in macrophages and MHC class-II molecule-expressing cells in the tubulointerstitium in response to uranyl acetate-induced acute renal failure in rats"Virchows Arch. 443. 206-216 (2003)
Fujigaki Y、Sun DF、Goto T、Hishida A:“肾小管间质中巨噬细胞和 MHC II 类分子表达细胞的暂时变化,响应乙酸铀酰诱导的大鼠急性肾衰竭”Virchows Arch。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fujimoto T, Fujigaki Y, Sun DF, Togawa A, Yonemura K, Hishida A: "Important role for fibronectin-EIIIA during renal tubular repair and cellular recovery in uranyl acetate-induced acute renal failure of rats"Virchows Arch. 443. 194-205 (2003)
Fujimoto T、Fujigaki Y、Sun DF、Tokawa A、Yonemura K、Hishida A:“纤连蛋白-EIIIA 在醋酸铀酰诱导的大鼠急性肾功能衰竭的肾小管修复和细胞恢复过程中的重要作用”Virchows Arch。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 6 条
The role of p21, a cell cycle regulation factor, in the development of cisplatin-induced acute renal failure
-
批准号:13671106
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:HISHIDA Akira
-
依托单位:
The role of apoptosis in cisplatin-induced acute renal failure.
-
批准号:10670993
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1998
-
负责人:HISHIDA Akira
-
依托单位:
The study on the factors which enhance the recovery from acute renal failure.
-
批准号:07671246
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.6万
-
财政年份:1995
-
负责人:HISHIDA Akira
-
依托单位:
The roles of endothelin and growth factors in ischemic acute renal failure.
-
批准号:04670385
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$0.51万
-
财政年份:1992
-
负责人:HISHIDA Akira
-
依托单位:
The role of anionic charge of the glomerular basement membrane.
-
批准号:63570288
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1988
-
负责人:HISHIDA Akira
-
依托单位:
国内基金
海外基金
登录
查看更多内容
UBE2D2负调控p27抑制细胞衰老促进胶质瘤进展的机制研究
-
批准号:2026JJ80431
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:孙学志
-
依托单位:
基于p27(KIP1)的磷酸化和亚细胞定位探讨周围神经修复机制及中药干预研究
-
批准号:2025JJ80967
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李洪辉
-
依托单位:
p27介导细胞铁死亡改善卵巢癌铂耐药的作用及机制研究
-
批准号:JCZRYB202500413
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
衰老性 Lamin A-Sirt6-P27 在衰老性脂肪组织
再分布中的作用研究
-
批准号:Q24H070004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:杨甜
-
依托单位:
E3泛素连接酶RNF6促进p27的泛素化降解影响胶质母细胞瘤的增殖和化疗敏感性
-
批准号:82103156
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:侯建兵
-
依托单位:
Ambra1通过Akt磷酸化FoxO1抑制p27转录促进乳腺癌细胞增殖和肿瘤发生的机制研究
-
批准号:82160499
-
项目类别:地区科学基金项目
-
资助金额:34.1万元
-
批准年份:2021
-
负责人:孙蔚亮
-
依托单位:
CDK2/p27/SKP2网络对视网膜母细胞瘤Y79细胞株c-MYC蛋白影响的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:
-
依托单位:
MLF1IP通过BRCA1/AKT/p27信号轴促进结直肠癌细胞增殖的机制研究
-
批准号:82002919
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:徐玉婷
-
依托单位:
SIRT2/TGF/smad/p27通路表观调控特发性肺纤维化的机制
-
批准号:2020JJ5802
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:段娟
-
依托单位:
p27上调PHLPP1改善卵巢癌铂耐药的机制研究
-
批准号:82002771
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:彭明刚
-
依托单位: